TheraLect AG is a biotechnology company developing topical applications of a recombinant plant lectin and reports positive Phase IIa results for epithelial healing following systemic administration.
AI-generated
Offering
Products & services
Industry:Licensing & Marketing of Intellectual Property
✓ Offered3
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Licensing of intellectual property rights to innovative life-science assets, followed by limited initial development and transfer into asset-oriented subsidiaries.
Development of life-science assets
Limited initial development of MedTech, Pharma, Biotech and Cosmeceutical assets, in particular topical applications, medical devices and pharmaceutical formulations.
Marketing and transaction preparation for assets
Establishment of asset-focused subsidiaries, value-driven further development and preparation of subsequent transactions for the benefit of shareholders.
Knowledge
No knowledge articles yet
Once TheraLect AG has claimed this profile, we'll publish editorial articles and case studies here together.